Free press releases distribution network?

Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



GE Healthcare Presents at 2013 BIO International Convention on Role of Precision Diagnostics and Reimbursement Policy - Chief Executive Officer for Medical Diagnostics Pascale Witz Serves on Industry Panel - GEHealthcare.com
GE Healthcare Presents at 2013 BIO International Convention on Role of Precision Diagnostics and Reimbursement Policy

 

PRZOOM - /newswire/ - Princeton, NJ, United States, 2013/04/23 - Chief Executive Officer for Medical Diagnostics Pascale Witz Serves on Industry Panel - GEHealthcare.com. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pascale Witz, President and CEO, GE Healthcare, Medical Diagnostics is serving on an industry panel at the 2013 BIO International Convention in Chicago, IL and will discuss how precision diagnostics are enabling providers to deliver the right treatment to the right patient at the right time. During her talk, Witz notes that while new drugs and targeted treatment have advanced the personalized medicine field considerably, the development of powerful diagnostics are required, and it is critical to have incentive for innovation in this field.

“Precision diagnostics are the new frontier and have a critical role to play in accelerating the transition from mass-market medicine to an era in which the needs of the individual are paramount,” said Witz. “But as we seek to enable providers to deliver the right treatment to the right patient at the right time, we stand at a crossroads. The current model of how these diagnostics are reimbursed must be addressed so that it works for payers, providers, clinicians and most importantly for patients who require access to life-saving treatment.”

Witz’s talk will focus specifically on using GE’s scale to deliver precision diagnostics to millions of patients, such that they might experience better health outcomes. She will also provide an overview of the reimbursement challenges associated with precision diagnostics, noting that the process for determining new payment levels for molecular diagnostics is in flux. There must be more process transparency, and the costs, clinical utility and overall value of the diagnostics should be taken into account.

"We need to develop reimbursement models that value precision diagnostics according to the benefits it brings,” said Witz.

About GE Healthcare

GE Healthcare (gehealthcare.com) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

Contact: Scott Lerman
P: 609-514-6346 / M: 609-937-9253 - E: Scott.Lerman[.]ge.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare Presents at 2013 BIO International Convention on Role of Precision Diagnostics and Reimbursement Policy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
GE News Center |
Contact: Aleisia Gibson 
609-514-6046 aleisia.gibson[.]ge.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From General Electric Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Al Rowaad Advocates & Legal Consultants

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today